DAREON Trademark

Trademark Overview


On Tuesday, June 20, 2023, a trademark application was filed for DAREON with the United States Patent and Trademark Office. The USPTO has given the DAREON trademark a serial number of 79378139. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, March 29, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The DAREON trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology
dareon

General Information


Serial Number79378139
Word MarkDAREON
Filing DateTuesday, June 20, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, March 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 8, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events


Event DateEvent Description
Friday, March 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 29, 2024REFUSAL PROCESSED BY MPU
Tuesday, March 12, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 11, 2024NON-FINAL ACTION WRITTEN
Friday, March 8, 2024ASSIGNED TO EXAMINER
Tuesday, September 12, 2023APPLICATION FILING RECEIPT MAILED
Friday, September 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB